Native LDL promotes differentiation of human monocytes to macrophages with an inflammatory phenotype

Summary

Recruitment of monocytes in atherosclerosis is dependent upon increased levels of plasma lipoproteins which accumulate in the blood vessel wall. The extracellular milieu can influence the phenotype of monocyte subsets (classical: CD14⁺⁺CD16^-, intermediate: CD14⁺CD16⁺ and non-classical: CD14^dimCD16⁺⁺) and macrophages (M1 or M2) and consequently the initiation, progression and/or regression of atherosclerosis. However, it is not known what effect lipoproteins, in particular native low-density lipoproteins (nLDL), have on the polarisation of monocyte-derived macrophages. Monocytes were differentiated into macrophages in the presence of nLDL. nLDL increased gene expression of the inflammatory cytokines TNFα and IL-6 in macrophages polarised towards the M1 phenotype while decreasing the M2 surface markers, CD206 and CD200R and the anti-inflammatory cytokines TGFβ and IL-10. Compared to the classical and intermediate subsets, the non-classical subset-derived macrophages had a reduced ability to respond to M1 stimuli (LPS and IFNγ). nLDL enhanced the TNFα and IL-6 gene expression in macrophages from all monocyte subsets, indicating an inflammatory effect of nLDL. Further, the classical and intermediate subsets both responded to M2 stimuli (IL-4) with upregulation of TGFβ and SR-B1 mRNA; an effect, which was reduced by nLDL. In contrast, the non-classical subset failed to respond to IL-4 or nLDL, suggesting it may be unable to polarise into M2 macrophages. Our data suggests that monocyte interaction with nLDL significantly affects macrophage polarisation and that this interaction appears to be subset dependent.

Supplementary Material to this article is available online at www.thrombosis-online.com.

Keywords

Monocyte subsets - macrophages - native LDL - polarisation

^* These authors contributed equally.

• References

• 1 Silverstein RL Inflammation, atherosclerosis, and arterial thrombosis: role of the scavenger receptor CD36. Clevel Clinic J Med 2009; 76 (Suppl. 02) S27-30.
• 2 Woollard KJ, Geissmann F. Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol 2010; 07: 77-86.
• 3 Zawada AM, Rogacev KS, Schirmer SH. et al. Monocyte heterogeneity in human cardiovascular disease. Immunobiol 2012; 217: 1273-1284.
• 4 Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nature Rev Immunol 2005; 05: 953-964.
• 5 Schlitt A, Heine GH, Blankenberg S. et al. CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels. Thromb Haemost 2004; 92: 419-424.
• 6 Tallone T, Turconi G, Soldati G. et al. Heterogeneity of human monocytes: an optimized four-color flow cytometry protocol for analysis of monocyte subsets. J Cardiovasc Transl Res 2011; 04: 211-219.
• 7 Wildgruber M, Lee H, Chudnovskiy A. et al. Monocyte subset dynamics in human atherosclerosis can be profiled with magnetic nano-sensors. PloS One 2009; 04: e5663.
• 8 Kashiwagi M, Imanishi T, Tsujioka H. et al. Association of monocyte subsets with vulnerability characteristics of coronary plaques as assessed by 64-slice multidetector computed tomography in patients with stable angina pectoris. Atherosclerosis 2010; 212: 171-176.
• 9 Imanishi T, Ikejima H, Tsujioka H. et al. Association of monocyte subset counts with coronary fibrous cap thickness in patients with unstable angina pectoris. Atherosclerosis 2010; 212: 628-635.
• 10 Urra X, Villamor N, Amaro S. et al. Monocyte subtypes predict clinical course and prognosis in human stroke. J Cerebr Blood Flow Metabol 2009; 29: 994-1002.
• 11 Tapp LD, Shantsila E, Wrigley BJ. et al. The CD14++CD16+ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction. J Thromb Haemost 2012; 10: 1231-1241.
• 12 Draude G, von Hundelshausen P, Frankenberger M. et al. Distinct scavenger receptor expression and function in the human CD14(+)/CD16(+) monocyte subset. Am J Physiol 1999; 276: H1144-1149.
• 13 Kapinsky M, Torzewski M, Buchler C. et al. Enzymatically degraded LDL preferentially binds to CD14(high) CD16(+) monocytes and induces foam cell formation mediated only in part by CD36. Arterioscl Thromb Vasc Biol 2001; 21: 1004-1010.
• 14 Mosig S, Rennert K, Krause S. et al. Different functions of monocyte subsets in familial hypercholesterolemia: potential function of CD14+ CD16+ monocytes in detoxification of oxLDL. FASEB J 2009; 23: 866-874.
• 15 Poitou C, Dalmas E, Renovato M. et al. CD14dimCD16+ and CD14+CD16+ monocytes in obesity and during weight loss: relationships with fat mass and subclinical atherosclerosis. Arterioscl Thromb Vasc Biol 2011; 31: 2322-2330.
• 16 Rothe G, Gabriel H, Kovacs E. et al. Peripheral blood mononuclear phagocyte subpopulations as cellular markers in hypercholesterolemia. Arterioscler Thromb Vasc Biol 1996; 16: 1437-1447.
• 17 Rothe G, Herr AS, Stohr J. et al. A more mature phenotype of blood mononuclear phagocytes is induced by fluvastatin treatment in hypercholesterolemic patients with CHD. Atherosclerosis 1999; 144: 251-261.
• 18 Coen PM, Flynn MG, Markofski MM. et al. Adding exercise to rosuvastatin treatment: influence on C-reactive protein, monocyte TLR4 expression, and inflammatory monocyte (CD14+CD16+) population. Metabolism Clin Exp 2010; 59: 1775-1783.
• 19 Nicolaou G, Erridge C. Toll-like receptor-dependent lipid body formation in macrophage foam cell formation. Curr Opin Lipidol 2010; 21: 427-433.
• 20 Gordon S. Alternative activation of macrophages. Nature Rev Immunol 2003; 03: 23-35.
• 21 Martinez FO, Sica A, Mantovani A. et al. Macrophage activation and polarisation. Frontiers Biosci 2008; 13: 453-461.
• 22 DallAsta M, Derlindati E, Ardigo D. et al. Macrophage polarisation: the answer to the diet/inflammation conundrum?. Nutrition Metabol Cardiovasc Dis 2012; 22: 387-392.
• 23 Pello OM, Silvestre C, De Pizzol M. et al. A glimpse on the phenomenon of macrophage polarisation during atherosclerosis. Immunobiology 2011; 216: 1172-1176.
• 24 Anzinger JJ, Chang J, Xu Q. et al. Native low-density lipoprotein uptake by macrophage colony-stimulating factor-differentiated human macrophages is mediated by macropinocytosis and micropinocytosis. Arterioscler Thromb Vasc Biol 2010; 30: 2022-2031.
• 25 Westerterp M, Koetsveld J, Yu S. et al. Increased atherosclerosis in mice with vascular ATP-binding cassette transporter G1 deficiency--brief report. Arterioscler Thromb Vasc Biol 2010; 30: 2103-2105.
• 26 Westerterp M, Murphy AJ, Wang M. et al. Deficiency of ATP-binding cassette transporters A1 and G1 in macrophages increases inflammation and accelerates atherosclerosis in mice. Circulation Res 2013; 112: 1456-1465.
• 27 Miller YI, Choi SH, Fang L. et al. Toll-like receptor-4 and lipoprotein accumulation in macrophages. Trends Cardiovasc Med 2009; 19: 227-232.
• 28 Libby P, Tabas I, Fredman G. et al. Inflammation and its resolution as determinants of acute coronary syndromes. Circulation Res 2014; 114: 1867-1879.
• 29 Viola J, Soehnlein O. Atherosclerosis - A matter of unresolved inflammation. Semin Immunol 2015; 27: 184-193.
• 30 Serrano Jr. CV, Pesaro AE, de Lemos JA. et al. Native LDL-cholesterol mediated monocyte adhesion molecule overexpression is blocked by simvastatin. Cardiovasc Drugs Ther 2009; 23: 215-220.
• 31 Murphy AJ, Dragoljevic D, Tall AR. Cholesterol efflux pathways regulate myelo-poiesis: a potential link to altered macrophage function in atherosclerosis. Front Immunol 2014; 05: 490.
• 32 Murphy AJ, Woollard KJ, Hoang A. et al. High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler Thromb Vasc Biol 2008; 28: 2071-2077.
• 33 Murphy AJ, Woollard KJ, Suhartoyo A. et al. Neutrophil activation is attenuated by high-density lipoprotein and apolipoprotein A-I in in vitro and in vivo models of inflammation. Arterioscler Thromb Vasc Biol 2011; 31: 1333-1341.
• 34 Sanson M, Distel E, Fisher EA. HDL induces the expression of the M2 macrophage markers arginase 1 and Fizz-1 in a STAT6-dependent process. PloS one 2013; 08: e74676.
• 35 Tolani S, Pagler TA, Murphy AJ. et al. Hypercholesterolemia and reduced HDL-C promote hematopoietic stem cell proliferation and monocytosis: studies in mice and FH children. Atherosclerosis 2013; 229: 79-85.
• 36 Murphy AJ, Akhtari M, Tolani S. et al. ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice. J Clin Invest 2011; 121: 4138-4149.
• 37 Murphy AJ, Funt S, Gorman D. et al. Pegylation of high-density lipoprotein decreases plasma clearance and enhances antiatherogenic activity. Circulation Res 2013; 113: e1-9.
• 38 Parihar A, Eubank TD, Doseff AI. Monocytes and macrophages regulate immunity through dynamic networks of survival and cell death. J Innate Immun 2010; 02: 204-215.
• 39 Cros J, Cagnard N, Woollard K. et al. Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 2010; 33: 375-386.
• 40 Zanoni I, Ostuni R, Marek LR. et al. CD14 controls the LPS-induced endocyto-sis of Toll-like receptor 4. Cell 2011; 147: 868-880.
• 41 Nagai Y, Garrett KP, Ohta S. et al. Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity 2006; 24: 801-812.
• 42 Tugal D, Liao X, Jain MK. Transcriptional control of macrophage polarisation. Arterioscler Thromb Vasc Biol 2013; 33: 1135-1144.
• 43 Netea MG, Kullberg BJ, Demacker PN. et al. Native LDL potentiate TNF alpha and IL-8 production by human mononuclear cells. J Lipid Res 2002; 43: 1065-1071.
• 44 Belge KU, Dayyani F, Horelt A. et al. The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J Immunol 2002; 168: 3536-3542.
• 45 Gautier EL, Jakubzick C, Randolph GJ. Regulation of the migration and survival of monocyte subsets by chemokine receptors and its relevance to atherosclerosis. Arterioscler Thromb Vasc Biol 2009; 29: 1412-1418.
• 46 Tacke F, Randolph GJ. Migratory fate and differentiation of blood monocyte subsets. Immunobiology 2006; 211: 609-618.
• 47 Ziegler-Heitbrock L. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukocyte Biol 2007; 81: 584-592.